Courtaut, F.; Aires, V.; Acar, N.; Bretillon, L.; Guerrera, I.C.; Chhuon, C.; Pais de Barros, J.-P.; Olmiere, C.; Delmas, D.
RESVEGA, a Nutraceutical Omega-3/Resveratrol Supplementation, Reduces Angiogenesis in a Preclinical Mouse Model of Choroidal Neovascularization. Int. J. Mol. Sci. 2021, 22, 11023.
https://doi.org/10.3390/ijms222011023
AMA Style
Courtaut F, Aires V, Acar N, Bretillon L, Guerrera IC, Chhuon C, Pais de Barros J-P, Olmiere C, Delmas D.
RESVEGA, a Nutraceutical Omega-3/Resveratrol Supplementation, Reduces Angiogenesis in a Preclinical Mouse Model of Choroidal Neovascularization. International Journal of Molecular Sciences. 2021; 22(20):11023.
https://doi.org/10.3390/ijms222011023
Chicago/Turabian Style
Courtaut, Flavie, Virginie Aires, Niyazi Acar, Lionel Bretillon, Ida Chiara Guerrera, Cerina Chhuon, Jean-Paul Pais de Barros, Céline Olmiere, and Dominique Delmas.
2021. "RESVEGA, a Nutraceutical Omega-3/Resveratrol Supplementation, Reduces Angiogenesis in a Preclinical Mouse Model of Choroidal Neovascularization" International Journal of Molecular Sciences 22, no. 20: 11023.
https://doi.org/10.3390/ijms222011023
APA Style
Courtaut, F., Aires, V., Acar, N., Bretillon, L., Guerrera, I. C., Chhuon, C., Pais de Barros, J.-P., Olmiere, C., & Delmas, D.
(2021). RESVEGA, a Nutraceutical Omega-3/Resveratrol Supplementation, Reduces Angiogenesis in a Preclinical Mouse Model of Choroidal Neovascularization. International Journal of Molecular Sciences, 22(20), 11023.
https://doi.org/10.3390/ijms222011023
